Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Spero Therapeutics, Inc. (SPRO) had Free Cash Flow per Share of $-0.07 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$5.87M |
|
$-13.87M |
|
-- |
|
$5.87M |
|
$20.61M |
|
$-14.73M |
|
$0.86M |
|
$-13.87M |
|
$-13.87M |
|
$-13.87M |
|
$-13.87M |
|
$-13.87M |
|
$-13.87M |
|
$-14.73M |
|
$-14.73M |
|
55.38M |
|
55.38M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$74.71M |
|
-- |
|
$3.00M |
|
$77.71M |
|
$29.16M |
|
-- |
|
$14.74M |
|
$43.90M |
|
$33.81M |
|
$33.81M |
|
$33.81M |
|
55.90M |
|
| Cash Flow Statement Financials | |
$-4.00M |
|
-- |
|
-- |
|
$52.89M |
|
$48.89M |
|
$-4.00M |
|
$1.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-250.78% |
|
-250.78% |
|
-- |
|
-236.06% |
|
-236.06% |
|
$-4.00M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
0.24 |
|
372.00 |
|
-41.01% |
|
-41.01% |
|
-17.84% |
|
-41.01% |
|
$0.60 |
|
|
Free Cash Flow per Share |
$-0.07 |
$-0.07 |
|